Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?

American Journal of Gastroenterology

Volumn 99, Issue 9, 2004, Pages 1726-1732

  Kanwal, Fasiha ^b   Hays, Ron D ^b   Kilbourne, Amy M ^b   Dulai, Gareth S ^b   Gralnek, Ian M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EVALUATION; HEALTH STATUS; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; QUALITY OF LIFE; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HEALTH SURVEYS; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LONG-TERM CARE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SICKNESS IMPACT PROFILE; SURVIVAL ANALYSIS;

EID: 4544297709     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.30300.x     Document Type: Article

References (38)

1. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
2. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-6.
3. Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: Moving towards evidence-based transplantation policy. Liver Transpl 2002;8:851-8.
4. United Network for Organ Sharing. 2002 annual report of the U.S. Scientific Registry for transplant recipients and the organ procurement and transplantation network: Transplant data. Chapter 7. Available at: www.optn.org/data/ar2002/ar02/chapter/seven.htm. Accessed on July 20, 2003.
5. Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001;120:170-8.
6. Younossi ZM, Guyatt G, Kiwi M, et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999;45:295-300.
7. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28:45-9.
8. Gralnek IM, Hays RD, Kilbourne A, et al. Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease-the LDQOL 1.0. Am J Gastroenterol 2000;95:3552-65.
9. Ware JE, Sherbourne CD. A 36-item short-form health survey (SF-36): Conceptual framework and item selection. Med Care 1992;30:473-83.
10. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item health survey 1.0. Health Econ 1993;2:217-27.
11. Ware JE, Snow KK, Kosinski M. SF-36 health survey: Manual and interpretation guide. Boston: The Health Institute, New England Medical Center. 1993.
12. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: A users manual. Boston: The Health Institute, New England Medical Center. 1994.
13. United network for organ sharing. Available at: www.unos.org/resources/ meldpeldcalculator. Accessed on June 1, 2002.
14. NSAS/STAT users guide, version 6, 4th Ed. Cary, NC: SAS Institute, 1990.
15. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994;106:287-96.
16. Meenan RF, Anderson JJ, Kazis LE, et al. Outcome assessment in clinical trials. Evidence for the sensitivity of a health status measure. Arthritis Rheum 1984;27:1344-52.
17. Kauppinen R, Sintonen H, Vilkka V, et al. Quality of life measures and clinical parameters in asthmatics during three year follow up. Monaldi Arch Chest Dis 1998;53:400-4.
18. Globe DR, Hays RD, Cunningham WE. Associations of clinical parameters with health-related quality of life in hospitalized persons with HIV disease. AIDS Care 1999;11:71-86.
19. Kim WR, Lindor KD, Malinchoc M, et al. Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease. Hepatology 2000;32:924-9.
20. Ganz PA, Coscarelli Schag CA, Kahn B, et al. Describing the health-related quality of life impact of HIV infection: Findings from a study using the HIV overview of problems-evaluation system (HOPES). Qual Life Res 1993;2:109-19.
21. Laupacis A, Wong C, Churchill D. The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. The Canadian Erythropoietin Study Group. Control Clin Trials 1991;12:168S-79S.
22. Wachtel T, Piette J, Mor V, et al. Quality of life in persons with human immunodeficiency virus infection: Measurement by the Medical Outcomes Study instrument. Ann Intern Med. 1992;116:129-37.
23. Kaplan RM, Anderson JP, Wu AW, et al. The quality of well-being scale. Applications in AIDS, cystic fibrosis, and arthritis. Med Care 1989;27:S27-43.
24. Hjortswang H, Almer S, Strom M. The network: A strategy to describe the relationship between quality of life and disease activity. The case of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999;11:1099-104.
25. Tarlov AR, Ware JE, Greenfield S, et al. The medical outcomes study. An application of methods for monitoring the results of medical care. JAMA 1989;262:925-30.
26. Ware JE Jr, Kosinski M, Bayliss MS, et al. A Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study. Med Care. 1995;33:AS264-79.
27. Cohen J. Statistical power analysis for the behavioural sciences. London: Academic Press; 1969.
28. Foster RJ, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998;27:209-12.
29. Fontana RJ, Mayor CA, Sonnad S, et al. Comorbidities and quality of life in patients with interferon refractory chronic hepatitis C. Am J Gastroenterol 2001;96:170-8.
30. Hussain KB, Fontana RJ, Mayor CA, et al. Comorbid illness is an important determinant of health related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001;96:2737-44.
31. Moore AA, Siu A, Partridge JM, et al. A randomized trial of office based screening for common problems in older persons. Am J Med 1997;102:371-8.
32. Wagner AK, Ehrenberg BL, Tran TA, et al. Patient based health status measurement in clinical practice: A study of its impact on epilepsy patients' care. Qual Life Res 1997;6:329-41.
33. Wasson J, Hays R, Rubenstein L, et al. The short-term effect of patient health status assessment in a health maintenance organization. Qual Life Res 1992;1:99-106.
34. Detmar SB, Aaronson NK. Quality of life assessment in daily clinical oncology practice: A feasibility study. Eur J Cancer 1998;34:1181-6.
35. McHorney CA. Health status assessment methods for adults: Past accomplishments and future challenges. Annu Rev Public Health 1999;20:309-35.
36. Lohr KN. Applications of health status assessment measures in clinical practice: Overview of the third conference on advances in health status assessment. Med Care 1992;30:MS1-MS14.
37. Till JE, Osoba D, Pater JL, et al. Research on health related quality of life: Dissemination into practical applications. Qual Life Res 1994;3:279-83.
38. Detmar SB, Muller MJ, Schornagel JH, et al. Health related quality of life assessments and patient physician communication. A randomized controlled trial. JAMA 2002;288:3027-34.